₿$73,459.79▼ 0.12%
AtaiBeckley Inc.
ATAI🇺🇸Reserve
ATAI Life Sciences N.V. (now Atai Beckley N.V.) is a clinical-stage biopharmaceutical company developing transformative mental health treatments. In March 2025, the company allocated $5M of existing cash reserves to purchase Bitcoin as a treasury diversification strategy.
BTC Holdings
99.8 BTC
180d
Stock PriceUpdated 11h ago
$4.53▲ 2.72%
180d
Total financing
0.00 USD
Insufficient history
mNAV
234.21x▲ 2.85%
180d
Sats/Share
26
180d
Mkt capFD
1.72B USD
SharesFD
379.04M
Fiat reserve
85.30M USD
Total reserve
92.63M USD
Leverage
0.0%
Dilution
3.0%
Analytics
FinancialsUnverified
US-GAAPQuarterlyAs of 2026-03-31
Balance Sheet
Total Assets$264.9M▲10.4%
Total Liabilities$66.1M▼17.3%
Stockholders' Equity$198.8M▲24.3%
Cash & Equivalents$43.1M▲41.8%
Total Debt—
Digital Assets$6.8M▼40.6%
Income Statement
Revenue$954K▲27.4%
Operating Income$-30.9M▼8.7%
Net Income$-29.8M▲51.2%
Interest Expense$0
Cash Flow
Operating Cash Flow$-21.1M▲9.3%
Instruments
| Instrument | Type | Exercise price | Warrant shares | Expiry | Outstanding |
|---|---|---|---|---|---|
| June 2025 Pre-Funded Warrant | Pre-funded | 0.0100 USD | 6.3M | — | 6.3M |
| July 2025 Pre-Funded Warrant | Pre-funded | 0.0100 USD | 4.6M | — | 4.6M |
| Total unexercised | 10.9M | ||||
Recent Changes
Fri, May 8, 2026
Shares Outstanding
365.6M→368.2M+2.6M(+0.7%)
Form 10-Q (Q1 2026)
Tue, Mar 31, 2026
Shares Outstanding
364.7M→365.6M+816.9K(+0.2%)
Form 10-Q (Q1 2026)
Fri, Feb 27, 2026
Shares Outstanding
363.2M→364.7M+1.6M(+0.4%)
Form 10-K (2025)
Wed, Dec 31, 2025
BTC Holdings
99→99.8+0.8 BTC(+0.8%)
Form 10-K (2025)
Fiat Reserve
30.4M→85.3M+54.9M(+180.6%)USD
Excludes $135.4M in securities carried at fair value held in the company's investment portfolio.
Form 10-K (2025)